In particular, the skin-derived KLK5, KLK7, and KLK14 have recently gained increasing attention as promising therapeutic targets in inflammatory skin disorders and cutaneous malignancies, such as the widespread atopic dermatitis and the rarer Netherton syndrome [294]. Here, KLK14 is linked to atopic eczema.